<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Peptide-MHC interactions &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/peptide-mhc-interactions/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 01 Jan 2026 15:19:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Peptide-MHC interactions &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ImmunoStruct: Advancing Deep Learning in Immunogenicity Prediction</title>
		<link>https://bioengineer.org/immunostruct-advancing-deep-learning-in-immunogenicity-prediction/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 01 Jan 2026 15:19:32 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[Immunogenicity prediction]]></category>
		<category><![CDATA[multimodal deep learning]]></category>
		<category><![CDATA[Peptide-MHC interactions]]></category>
		<category><![CDATA[Vaccine design]]></category>
		<guid isPermaLink="false">https://bioengineer.org/immunostruct-advancing-deep-learning-in-immunogenicity-prediction/</guid>

					<description><![CDATA[In the realm of immunology, the search for effective vaccines against infectious diseases and cancer has led to the exploration of epitope-based therapeutics. Epitopes, the specific regions of antigens that are recognized by the immune system, serve as critical components in vaccine development. However, the challenge lies in accurately identifying immunogenic epitopes that elicit a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312783</post-id>	</item>
	</channel>
</rss>
